Subjects will undergo a placebo and allopurinol phase to better understand the effects of the reduced function BCRP Q141K variant on allopurinol pharmacokinetics and pharmacodynamics.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
27
lactose placebo pill
Open Medicine Institute
Mountain View, California, United States
Oxypurinol Renal Clearance
Renal clearance as defined by amount excreted in 24 hours/AUC from 0-24 hours
Time frame: 24 hours (Urine collected 0-4 hrs,4-8 hrs,8-10 hrs,10-24 hrs post-dose)
Percent Change Uric Acid
Maximum percent change in uric acid after a single dose of allopurinol
Time frame: 24 hours
Oxypurinol AUC
Area under the concentration time curve from 0-24 hours following a single dose of allopurinol (i.e. Day 1 of both protocols)
Time frame: 24 hours (Collections at 0, 0.5, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, 24 hours post-dose)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.